EuroMedica Clinical Glutathione features Sublinthion® , a unique, protected glutathione from France produced by a patented process.
In a published human study, Clinical Glutathione with Sublinthion improved the reduced glutathione vs. oxidized glutathione blood ratios in the body by 230%.*†
Clinical Glutathione is specially formulated as a slow-melt tablet, protected by a unique, patented process. It supports beneficial levels of active glutathione in the bloodstream and improves the ratio of active glutathione to oxidized glutathione in a way that other approaches can’t.*
- Improves blood ratios by 230%*†
- Slow melt tablet for optimal benefits
- Clinically tested, European innovation
- Exclusive, patented, protected delivery system
Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.